Future prospects for treating rectal cancer
Kai-Keen Shiu, MRCP, PhD, of University College London Hospitals NHS Foundation Trust, London, UK, speaks to us about future directions for the treatment of rectal cancer at the UK Oncology Forum (OF)... Author: VJOncology Added: 07/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Diagnosing and treating Gaucher disease
Speaking from the British Society for Hematology (BSH) 2018 Annual Scientific Meeting in Liverpool, UK, Derralyn Hughes, MA, DPhil, FRCP, FRCPath, of the Royal Free London NHS Foundation Trust, London... Author: VJHemOnc Added: 07/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 4, 2018 Category: Cancer & Oncology Source Type: podcasts

BOPA updates: bursary scheme and digital content for oncology pharmacists
At the UK Oncology Forum (OF) 2018, held in Liverpool, UK, Steve Williamson, from Northumbria NHS Foundation Trust, Newcastle upon Tyne, UK, provides an update on the lastest activities of the British... Author: VJOncology Added: 06/27/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2018 Category: Cancer & Oncology Source Type: podcasts

Improving imaging guidelines for multiple myeloma
Guy Pratt, MD, FRCP, FRCPath, of University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, discusses recent guideline changes within multiple myeloma (MM) diagnostics and treatment, focusi... Author: VJHemOnc Added: 06/27/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2018 Category: Cancer & Oncology Source Type: podcasts

Challenges in MM guideline implementation
Challenges are often encountered when implementing guidelines into clinical practice. Here, Guy Pratt, MD, FRCP, FRCPath, of the University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, d... Author: VJHemOnc Added: 06/27/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2018 Category: Cancer & Oncology Source Type: podcasts

Olaparib plus abiraterone for mCRPC: are biomarkers necessary?
Gerhardt Attard, MD, PhD, FRCP, of the The Royal Marsden NHS Foundation Trust, London, UK, speaks from the UK Oncology Forum (OF) 2018, held in Liverpool, UK, on the topic of metastatic castration-res... Author: VJOncology Added: 06/25/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 25, 2018 Category: Cancer & Oncology Source Type: podcasts

Is the oral care of cancer patients being neglected?
Sonja Hoy, BS, PGDip, of The Royal Marsden NHS Foundation Trust, London, UK, discusses the importance of good oral hygiene in cancer patients at the UK Oncology Forum (OF) 2018, held in Liverpool, UK.... Author: VJOncology Added: 06/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2018 Category: Cancer & Oncology Source Type: podcasts

EBMT 2018: Investigating breakthrough therapies for treating AML in adults
Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, from University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, outlines the breakthrough therapies for the treatment of acute myeloid leuk... Author: VJHemOnc Added: 05/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Case study: the importance of consent and disclosure in transplantation
Consent for transplant, from both the patient and healthcare professionals, is critical. In this interview, Angela Leather from the Christie NHS Foundation Trust, Manchester, UK, recollects a case tha... Author: VJHemOnc Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Post-transplant complications in women: unseen GvHD
Post-transplant complications are an important issue to consider and must be managed appropriately. Here, Angela Leather from the Christie NHS Foundation Trust, Manchester, UK, talks about the problem... Author: VJHemOnc Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Professional education and training on the management CAR T-cell toxicities
CAR T-cell agents, as a breakthrough therapy, have their challenges. Here, Rose Ellard from Kings College Hospital NHS Foundation Trust, London, UK, outlines the importance of formal training in mana... Author: VJHemOnc Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Cytokine release syndrome in CAR T-cell therapy
CAR T-cell therapy is a new and exciting advancement for the treatment of hematological cancers. In this interview, Rose Ellard from Kings College Hospital NHS Foundation Trust, London, UK, talks abo... Author: VJHemOnc Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Tracking the evolution of renal cell carcinoma: TRACERx Renal
Samra Turajlic, Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust <br />CRUK Clinician Scientist, The Francis Crick Institute discusses Tracking the evolution of renal cell carcinoma: ... Author: kidneycancer Added: 04/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 29, 2018 Category: Cancer & Oncology Source Type: podcasts

The neo-antigen landscape in renal cell carcinoma
Samra Turajlic, Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust CRUK Clinician Scientist, The Francis Crick Institute discusses the neo-antigen landscape in renal cell carcinoma ... Author: kidneycancer Added: 04/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 28, 2018 Category: Cancer & Oncology Source Type: podcasts

Immunotherapy: Bridging Knowledge from Melanoma
Dr James Larkin, Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust discusses "Immunotherapy: Bridging Knowledge from Melanoma" from a Kidney Cancer point of view at the 13th Eur... Author: kidneycancer Added: 04/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 28, 2018 Category: Cancer & Oncology Source Type: podcasts